Purchase of an Agilent ICP-MS/MS

The Food and Drug Administration is forecasting the purchase of an Agilent ICP-MS/MS instrument to support high-priority research at Moffett related to the effects of toxic elements. This acquisition is essential for advancing the agency’s elemental analysis capabilities within its packaging and chemical contaminant research program, ensuring accurate detection and quantification of hazardous substances. The need arises from critical scientific demands requiring advanced mass spectrometry technology to meet evolving regulatory and public health obligations. The solicitation is classified under NAICS code 541990 and is posted as a forecast with no set-aside designation, indicating it is open to all eligible vendors. The primary point of contact for program inquiries is the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. The equipment will be used at a location managed by the FDA, though specific performance address details are not provided. This procurement reflects an urgent investment in laboratory infrastructure to enhance analytical precision and support ongoing toxicological research.